Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties

被引:47
|
作者
Kela, J
Salmi, P
Rimondini-Giorgini, R
Heilig, M
Wahlestedt, C
机构
[1] Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden
[2] Huddinge Univ Hosp, Dept NEUROTEC, Karolinska Inst, SE-14186 Stockholm, Sweden
关键词
food intake; anxiety; body temperature; thermoregulation; locomotor activity; exploratory behaviour;
D O I
10.1016/S0167-0115(03)00114-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Melanin-concentrating hormone (MCH) is a cyclic neuropeptide, predominantly expressed in hypothalamus, and recognized as a key regulator in feeding behaviour and energy balance. In this study, we examined the behavioural effects of intracerebroventricularly administered MCH on food intake, anxiety, exploratory behaviour and body core temperature in rats. MCH (0.15-10.0 mug, i.c.v.) acutely increased food intake in a dose-dependent manner. In addition, MCH (0.6-10.0 mug, i.c.v.) produced effects similar to anxiolytics in an animal model of anxiety, Vogel's punished drinking test. Thus, punished drinking episodes were significantly increased. We found no effects of MCH (5.0-20.0 mug, i.c.v.) on locomotor activity either in habituated or non-habituated animals. Furthermore, MCH did not produce any changes in body core temperature. Together, these observations further support a role for MCH as an orexigenic neuropeptide and also suggest anti-anxiety proper-ties for MCH. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [1] Involvement of the opioid system in the orexigenic and hedonic effects of melanin-concentrating hormone
    Lopez, Carlos Andres
    Guesdon, Benjamin
    Baraboi, Elena-Dana
    Roffarello, Boris Monge
    Hetu, Marylene
    Richard, Denis
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2011, 301 (04) : R1105 - R1111
  • [2] The orexigenic effect of melanin-concentrating hormone (MCH) is influenced by sex and stage of the estrous cycle
    Santollo, Jessica
    Eckel, Lisa A.
    PHYSIOLOGY & BEHAVIOR, 2008, 93 (4-5) : 842 - 850
  • [3] Estradiol decreases the orexigenic effect of melanin-concentrating honnone in ovariectomized rats
    Messina, Michelina M.
    Boersma, Gretha
    Overton, J. Michael
    Eckel, Lisa A.
    PHYSIOLOGY & BEHAVIOR, 2006, 88 (4-5) : 523 - 528
  • [4] The regulation of alcohol intake by melanin-concentrating hormone in rats
    Duncan, Elizabeth A.
    Rider, Therese R.
    Jandacek, Ronald J.
    Clegg, Deborah J.
    Benoit, Stephen C.
    Tso, Patrick
    Woods, Stephen C.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 85 (04) : 728 - 735
  • [5] Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats
    Stricker-Krongrad, A
    Dimitrov, T
    Beck, B
    MOLECULAR BRAIN RESEARCH, 2001, 92 (1-2): : 43 - 48
  • [6] Melanin-concentrating hormone promotes feeding through the lateral septum
    Payant, Mikayla A.
    Shankhatheertha, Anjali
    Chee, Melissa J.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2025, 136
  • [7] Regulation of food intake by melanin-concentrating hormone in goldfish
    Matsuda, Kouhei
    Kojima, Kenji
    Shimakura, Sei-Ichi
    Takahashi, Akiyoshi
    PEPTIDES, 2009, 30 (11) : 2060 - 2065
  • [8] Melanin-concentrating hormone and its receptors: state of the art
    Boutin, JA
    Suply, T
    Audinot, V
    Rodriguez, M
    Beauverger, P
    Nicolas, JP
    Galizzi, JP
    FauchFre, JL
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (05) : 388 - 395
  • [9] The role of melanin-concentrating hormone in conditioned reward learning
    Sherwood, Andrew
    Wosiski-Kuhn, Marlena
    Truc Nguyen
    Holland, Peter C.
    Lakaye, Bernard
    Adamantidis, Antoine
    Johnson, Alexander W.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2012, 36 (08) : 3126 - 3133
  • [10] Melanin-concentrating hormone functions in the nervous system: food intake and stress
    Hervieu, G
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (04) : 495 - 511